Management of menopausal women with a history of endometriosis

1. Юренева С.В., Ермакова Е.И. Ведение женщин с менопаузальными расстройствами (обзор клинических рекомендаций). Проблемы репродукции. 2017; 23(5): 115–22. [Yureneva S.V., Ermakova E.I. The management of women with menopausal disorders (review of clinical guidelines). Russian Journal of Human Reproduction/Problemy reproduktsii. 2017; 23(5):115–22. (in Russian)]. doi:10.17116/repro2017235115-122
2. Baber R.J., Panay N., Fenton A., and the IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016; 19(2):109–50. doi: 10.3109/13697137.2015.1129166.
3. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017; 24(7): 728–53. doi: 10.1097/GME.0000000000000921.
4. Stuenkel C.A., Davis S.R., Gompel A. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab. 2015; 100(11): 3975–4011. doi: 10.1210/jc.2015-2236.
5. Black A., Guilbert E., Costescu D., Dunn S., Fisher W., Kives S., Mirosh M., Norman W., Pymar H., Reid R., Roy G., Varto H., Waddington A., Wagner M.S., Whelan A.M., Mansouri S. Canadian Contraception Consensus (Part 3 of 4): Chapter 7. Intrauterine Contraception. J Obstet Gynaecol Can. 2016; 38(2): 182–222. doi: 10.1016/j.jogc.2015.12.002. [Article in English, French]
6. Юренева С.В., Ермакова Е.И. Менопауза и климактерическое состояние у женщины. Акушерство и гинекология. 2018; 7: 32–9. [Yureneva S.V., Ermakova E.I. Menopause and menopausal status in a woman. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (7): 32–8. (in Russian)]. https://dx.doi.org/10.18565/aig.2018.7.32-38
7. Streuli I., Gaitzsch H., Wenger J.M., Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric. 2017; 20(2): 138–43. doi: 10.1080/13697137.2017.1284781.
8. Al Kadri H., Hassan S., Al-Fozan H.M., Hajeer A. Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev. 2009; (1): CD005997. doi: 10.1002/14651858.CD005997.pub2.
9. Shuster L.T., Rhodes D.J., Gostout B.S., Grossardt B.R., Rocca W.A. Premature menopause or early menopause: long-term health consequences. Maturitas. 2010; 65:161–6. doi: 10.1016/j.maturitas.2009.08.003.
10. Inceboz U. Endometriosis after menopause. Womens Health. 2015; 11(5): 711–5. doi: 10.2217/whe.15.59.
11. Moen M.H., Rees M., Brincat M., Erel T., Gambaccianif M., Lambrinoudakig I., Schenck-Gustafssonh K., Tremollieresi F., Vujovicj S., Rozenberg S. EMAS position statement: Managing the menopause in women with a past history of endometriosis. Maturitas. 2010; 67(1): 94–7. doi: 10.1016/j.maturitas.2010.04.018.
12. Henriksen E. Endometriosis. Am J Surg. 1955; 90(2): 331–7. doi: 10.1016/0002-9610(55)90765-0
13. Punnonen R., .Nikkanen V. External endometriosis in 801 operated patients. Acta Obstet Gynecol Scand. 1984; 63(8): 699–701. PMID: 6524304
14. Haas D., Chvatal R., Reichert B. Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet. 2012; 286(3): 667–70. doi: 10.1007/s00404-012-2361-z.
15. Fedele L., Bianchi S., Raffaelli R., Zanconato G. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas. 1999; 32(3): 189–93. doi: 10.1016/s0378-5122(99)00032-8
16. Matorras R., Elorriaga M.A., Pioan J.I., Ramon O., Rodriguez-Escudero F.J. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002; 77(2): 303–308. doi: 10.1016/s0015-0282(01)02981-8
17. Rattanachaiyanont M., Tanmahasamut P., Angsuwatthana S., Techatraisak K., Inthawiwat S., Leerasiri P. Hormonal replacement therapy in surgical menopause with underlying endometriosis. J Med Assoc Thai. 2005; 86(8): 702–7. PMID: 12948267
18. Hickman T.N., Namnoum A.B., Hinton E.L., Zacur H.A., Rock J.A. Timing of estrogen replacement therapy following hysterectomy with oophorectomy for endometriosis. Obstet Gynecol. 1998; 91(5 Pt 1): 673–7.doi: 10.1016/s0029-7844(98)00071-4
19. Takayama K., Zeitoun K., Gunby R.T., Sasano H., Carr B.R., Bulun S.E. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998; 69(4): 709–13. doi:10.1016/S0015-0282(98)00022-3.
20. Bohrer J., Chen C.C., Falcone T. Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor. Fertil Steril. 2008; 90(5): 2004. e7-9. doi: 10.1016/j.fertnstert.2008.03.040.
21. Sasson I.E., Taylor H.S. Aromatase inhibitor for treatment of a recurrent abdominal wall endometrioma in a postmenopausal woman. Fertil Steril. 2009: 92(3): e1-4. doi: 10.1016/j.fertnstert.2009.05.071.
22. Modesitt S.C., Tortolero-Luna G., Robinson J.B., Gershenson D.M., Wolf J.K. Ovarian and extraovarian endometriosis–associated cancer. Obstet Gynecol. 2002; 100(4): 788–95. doi: 10.1016/s0029-7844(02)02149-x
23. Thomsen L.H., Schnack T.H., Buchardi K. Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review. Acta Obstet Gynecol Scand. 2017; 96: 761–78. doi: 10.1111/aogs.13010.

Received 02.209.2019

Accepted 04.10.2019